These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6259601)

  • 1. [Place of cefotaxime in the treatment of septicaemias due to enterobacteriaceae (author's transl)].
    Bastin R; Frottier J; Vilde JL; Bure A
    Nouv Presse Med; 1981 Feb; 10(8):598-600. PubMed ID: 6259601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cefotaxime in septicaemia and severe infections due to multiresistant Gram-negative bacilli (author's transl)].
    Dureux JB; Canton P; Roche G; Weber M; Gérard A
    Nouv Presse Med; 1981 Feb; 10(8):601-6. PubMed ID: 6259602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of Gram-negative septicaemia with cefotaxime: 16 cases (author's transl)].
    Goulon M; Gajdos P; Pilliot J
    Nouv Presse Med; 1981 Feb; 10(8):613-6. PubMed ID: 6259604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cefotaxime treatment of 25 cases of severe enterobacteriaceae infections in an intensive care unit (author's transl)].
    Motin J; Bouletreau P; Auboyer C; Bui-Xuan B; Flandrois JP; Reverdy ME
    Nouv Presse Med; 1981 Feb; 10(8):617-21. PubMed ID: 6259605
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cefotaxime and Gram-negative infections in children. Effectiveness and tolerance (author's transl)].
    Aufrant C; Lambert-Zechovsky N; Aujard Y; Bingen E; Blum C; Beaufils F; Mathieu H
    Nouv Presse Med; 1981 Feb; 10(8):639-46. PubMed ID: 6259610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cefotaxime in digestive tract infections (author's transl)].
    Paris J; Paris JC; Gérard A
    Nouv Presse Med; 1981 Feb; 10(8):647-9. PubMed ID: 6259611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cefotaxime in the treatment of severe infections due to multiresistant Gram-negative bacilli (author's transl)].
    Clumeck N; Van Laethem Y; Vanhoof R; Jaspar N; George G; Rapin M; Butzler JP
    Nouv Presse Med; 1981 Feb; 10(8):622-4. PubMed ID: 6259606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The use of cefotaxime against infections (author's transl)].
    Lepeu G; Bertrand A; Armengaud M; Aubertin J
    Nouv Presse Med; 1981 Feb; 10(8):594-7. PubMed ID: 6259600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical evaluation of cefotaxime at various dosage levels in urinary tract infections (author's transl)].
    Guibert J; Acar JF; Justin C; Kitzis MD
    Nouv Presse Med; 1981 Feb; 10(8):625-7. PubMed ID: 6259607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cefotaxime in bronchopulmonary infections (author's transl)].
    Kermarec J; Sauvaget J
    Nouv Presse Med; 1981 Feb; 10(8):650-3. PubMed ID: 6259612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical experience of cefotaxime (author's transl)].
    Portier H; Carbon C; Boussougant Y; Destaing F
    Nouv Presse Med; 1981 Feb; 10(8):607-11. PubMed ID: 6259603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cefotaxime in the treatment of purulent meningitis in children (author's transl)].
    Borderon JC; Despert F; Santini JJ; Laugier J; Grenier B; Boulard P
    Nouv Presse Med; 1981 Feb; 10(8):634-8. PubMed ID: 6259609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cefotaxime in childhood infections (author's transl)].
    Garnier JM; Giraud F
    Nouv Presse Med; 1981 Feb; 10(8):629-33. PubMed ID: 6259608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical use of new cephalosporins for severe infections in internal medicine].
    Stille W
    Wien Klin Wochenschr Suppl; 1983; 142():18-20. PubMed ID: 6316668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of the efficacy of cefotaxime alone and the combination cefazolin-tobramycin in the treatment of enterobacterial septicemia].
    Arich C; Gouby A; Bengler C; Ardilouze JL; Dubois A; Joubert P; Hansel S; Janbon C; Fabre S
    Pathol Biol (Paris); 1987 May; 35(5):613-5. PubMed ID: 3302868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Enterobacter cloacae and E. aerogenes septicemia: emergence of resistant variants (derepressed cephalosporinase) during treatment with third-generation cephalosporins].
    Nauciel C; Philippon A; Ronco E; Pilliot J; Guenounou M; Paul G; Brunel D; Outin HD
    Presse Med; 1985 Mar; 14(12):673-6. PubMed ID: 3157961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefotaxime (C) vs cefotaxime + amikacin (C + A) in the treatment of septicemia due to enterobacteria: a multicenter study.
    Carbon C; Auboyer C; Becq-Giraudon B; Bertrand P; Gallais H; Mouton Y; Motin JP; Vachon F; Wasmer JM; Buré A
    Chemioterapia; 1987 Jun; 6(2 Suppl):367-8. PubMed ID: 3334576
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessment of the clinical significance of production of extended-spectrum beta-lactamases (ESBL) by Enterobacteriaceae.
    Henshke-Bar-Meir R; Yinnon AM; Rudensky B; Attias D; Schlesinger Y; Raveh D
    Infection; 2006 Apr; 34(2):66-74. PubMed ID: 16703295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Concentrations of cefotaxime in human tissues and fluids. A review of published data (author's transl)].
    Galy J; Mantel O
    Nouv Presse Med; 1981 Feb; 10(8):565-73. PubMed ID: 6259594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo and in vitro emergence of simultaneous resistance to both beta-lactam and aminoglycoside antibiotics in a strain of Serratia marcescens.
    Goldstein FW; Gutmann L; Williamson R; Collatz E; Acar JF
    Ann Microbiol (Paris); 1983; 134A(3):329-37. PubMed ID: 6357025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.